A Promising New Treatment For Autoimmune Diseases

mycobacterium vaccae a promising new treatment for autoimmune diseases 4897

mycobacterium vaccae a promising new treatment for autoimmune diseases 4897

Rate this post

Mycobacterium vaccae, or M. vacca, is a beneficial bacteria that has been used in the treatment of inflammatory and autoimmunity disorders. According to the International Patent Specification PCT/GB90/01318, M. vaccae is useful in the treatment of inflammatory and chronic disorders caused by abnormally high levels of the cytokine interleukin-6 produced by macrophages. It may also be useful in the treatment of primary diabetes mellitus and graft rejection.

Mycobacterium Vaccae

In a mouse model, M. vaccae treatment reduced eosinophilic inflammation. In addition, a single challenge with OVA aerosol resulted in a significant increase in BAL fluid. The highest levels of neutrophils were detected between four and 24 h after the OVA challenge. Moreover, the treatment was safe and did not interfere with the established immune response.

Supplements That Increase Spermidine Could Improve Your Health

A nebulized strain of Mycobacterium vaccae is safe and effective in mice with allergic bronchial asthma. In humans, the strains have been extensively studied in the treatment of tuberculosis and cancer. Female BALB/c mice were used for the study buy spermidine. All the procedures followed the Home Office’s 1986 Animal Scientific Act and were approved by the Novartis Horsham Research Center’s animal welfare committee.

The bacterial strains M. vaccae produces inhibit the infiltration of inflammatory cells in BAL fluid. This inhibition occurs independently of IFN-g and is Ag specific. Further studies are needed to determine the exact mechanism behind these effects. In the meantime, bacteria are already a promising alternative to existing medications. When combined with anti-allergic drugs, it may provide an alternative to conventional medications.